We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Privacy Terms and Cookie Policy
Shining Light on Farm & Food Policy for 20 Years.
Wednesday, January 01, 2025
Stakeholders offered a tepid response to Food and Drug Administration Commissioner Robert Califf’s unveiling Tuesday of a new Humans Foods Program, which Califf said he believes will fundamentally transform the way FDA oversees the U.S. food supply.
Food and Drug Administration Commissioner Robert Califf has proposed creating a new Human Foods Program at the agency and has begun a national search for a newly created deputy commissioner for human foods who would report directly to him.
The Food and Drug Administration will use an outside evaluation released Tuesday to help reform its human foods program, FDA Commissioner Robert Califf said following release of the report by the Reagan-Udall Foundation.
Is a seaweed feed additive which can significantly reduce methane emissions considered a feed ingredient or animal drug? What about an animal food ingredient which could actually reduce the risk of salmonella? According to current Food and Drug Administration policy, the answer is an animal drug, adding years and additional cost to gain approval from FDA.
Steven Solomon, director of the FDA’s Center for Veterinary Medicine, plans to retire at the end of this year, according to an agency email obtained by Agri-Pulse.
Panel members appointed to evaluate the Food and Drug Administration’s human foods programs have their work cut out for them as they craft recommendations for FDA leadership.
The Food and Drug Administration has for the first time approved an intentional genomic alteration, or IGA, in animals that can be used for both food and human therapeutics.
The Food and Drug Administration, facing increased criticism of its regulatory process for gene-edited animals, is mounting a new effort to defend its policies to farmers, researchers and developers, but the industry is backing the Agriculture Department's push to take over some of FDA's oversight role.
Dana O’Brien is the executive vice president of food & agriculture at Biotechnology Innovation Organization (BIO) and in this piece he shares his thoughts on improving the regulatory system for animal biotechnology.
